231 related articles for article (PubMed ID: 22976327)
1. Component crystallization and physical collapse during freeze-drying of L-arginine-citric acid mixtures.
Yamaki T; Ohdate R; Nakadai E; Yoshihashi Y; Yonemochi E; Terada K; Moriyama H; Izutsu K; Yomota C; Okuda H; Kawanishi T
Chem Pharm Bull (Tokyo); 2012; 60(9):1176-81. PubMed ID: 22976327
[TBL] [Abstract][Full Text] [Related]
2. Effects of formulation and process factors on the crystal structure of freeze-dried Myo-inositol.
Izutsu K; Yomota C; Okuda H; Kawanishi T; Yamaki T; Ohdate R; Yu Z; Yonemochi E; Terada K
J Pharm Sci; 2014 Aug; 103(8):2347-55. PubMed ID: 24916801
[TBL] [Abstract][Full Text] [Related]
3. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
4. Physical characterization of meso-erythritol as a crystalline bulking agent for freeze-dried formulations.
Fujii K; Izutsu K; Kume M; Yoshino T; Yoshihashi Y; Sugano K; Terada K
Chem Pharm Bull (Tokyo); 2015; 63(5):311-7. PubMed ID: 25948324
[TBL] [Abstract][Full Text] [Related]
5. Freeze-drying of proteins with glass-forming oligosaccharide-derived sugar alcohols.
Kadoya S; Fujii K; Izutsu K; Yonemochi E; Terada K; Yomota C; Kawanishi T
Int J Pharm; 2010 Apr; 389(1-2):107-13. PubMed ID: 20097277
[TBL] [Abstract][Full Text] [Related]
6. Effects of solute miscibility on the micro- and macroscopic structural integrity of freeze-dried solids.
Izutsu K; Fujii K; Katori C; Yomota C; Kawanishi T; Yoshihashi Y; Yonemochi E; Terada K
J Pharm Sci; 2010 Nov; 99(11):4710-9. PubMed ID: 20845467
[TBL] [Abstract][Full Text] [Related]
7. Miscibility as a factor for component crystallization in multisolute frozen solutions.
Izutsu KI; Shibata H; Yoshida H; Goda Y
J Pharm Sci; 2014 Jul; 103(7):2139-2146. PubMed ID: 24903048
[TBL] [Abstract][Full Text] [Related]
8. Fundamentals of freeze-drying.
Nail SL; Jiang S; Chongprasert S; Knopp SA
Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
[TBL] [Abstract][Full Text] [Related]
9. Effect of co-solutes and process variables on crystallinity and the crystal form of freeze-dried myo-inositol.
Izutsu KI; Kusano R; Arai R; Yoshida H; Ito M; Shibata H; Sugano K; Goda Y; Terada K
Int J Pharm; 2016 Jul; 509(1-2):368-374. PubMed ID: 27282535
[TBL] [Abstract][Full Text] [Related]
10. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
Liu D; Galvanin F; Yu Y
AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
[TBL] [Abstract][Full Text] [Related]
11. Glass-state amorphous salt solids formed by freeze-drying of amines and hydroxy carboxylic acids: effect of hydrogen-bonding and electrostatic interactions.
Kadoya S; Izutsu K; Yonemochi E; Terada K; Yomota C; Kawanishi T
Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):821-6. PubMed ID: 18520087
[TBL] [Abstract][Full Text] [Related]
12. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
[TBL] [Abstract][Full Text] [Related]
13. Collapse temperature of freeze-dried Lactobacillus bulgaricus suspensions and protective media.
Fonseca F; Passot S; Cunin O; Marin M
Biotechnol Prog; 2004; 20(1):229-38. PubMed ID: 14763847
[TBL] [Abstract][Full Text] [Related]
14. Protein purification process engineering. Freeze drying: A practical overview.
Gatlin LA; Nail SL
Bioprocess Technol; 1994; 18():317-67. PubMed ID: 7764173
[TBL] [Abstract][Full Text] [Related]
15. Amorphous-Amorphous Phase Separation of Freeze-Concentrated Protein and Amino Acid Excipients for Lyophilized Formulations.
Izutsu KI; Yoshida H; Shibata H; Goda Y
Chem Pharm Bull (Tokyo); 2016; 64(12):1674-1680. PubMed ID: 27904076
[TBL] [Abstract][Full Text] [Related]
16. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
[TBL] [Abstract][Full Text] [Related]
17. Effects of sodium tetraborate and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids.
Izutsu K; Ocheda SO; Aoyagi N; Kojima S
Int J Pharm; 2004 Apr; 273(1-2):85-93. PubMed ID: 15010133
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.
Kasraian K; Spitznagel TM; Juneau JA; Yim K
Pharm Dev Technol; 1998 May; 3(2):233-9. PubMed ID: 9653761
[TBL] [Abstract][Full Text] [Related]
19. Controlling the physical form of mannitol in freeze-dried systems.
Mehta M; Bhardwaj SP; Suryanarayanan R
Eur J Pharm Biopharm; 2013 Oct; 85(2):207-13. PubMed ID: 23643784
[TBL] [Abstract][Full Text] [Related]
20. Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry.
Cavatur RK; Suryanarayanan R
Pharm Dev Technol; 1998 Nov; 3(4):579-86. PubMed ID: 9834962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
